Trelegy ellipta 200-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FADLU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,869
Award facts
- Contract value 100% obligated
- $25,868.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $25,868.99 to AmerisourceBergen Drug Corp for the supply of Trelegy Ellipta 200-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The contract, awarded on November 26, 2025, is a firm fixed-price delivery order with an ultimate completion date of November 28, 2025. This award represents a non-competitive purchase under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, a $1 billion global pharmaceutical support vehicle designated SPE2DX that runs through December 2026. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania.
This delivery order falls within AmerisourceBergen's broader role as a critical pharmaceutical distributor for federal medical procurement, particularly serving the Defense Health Agency and military healthcare systems. As a major pharmaceutical vendor with extensive federal contract experience, AmerisourceBergen supplies brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The underlying IDC vehicle enables the company to respond efficiently to recurring pharmaceutical needs across the military health system, allowing DLA to procure essential medications through pre-established pricing and terms rather than conducting competitive solicitations for individual transactions.
Quick answers
Who was awarded contract SPE2DR26FADLU?
SPE2DR26FADLU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 26, 2025.
How much is contract SPE2DR26FADLU worth?
The government has obligated $25,869 on SPE2DR26FADLU.
Is contract SPE2DR26FADLU an order under another contract?
Yes. SPE2DR26FADLU is a delivery order under SPE2DR25D2011, an indefinite delivery contract.
Was contract SPE2DR26FADLU competed?
The extent of competition for SPE2DR26FADLU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award